Scholars Central

Research articlePublished 6 Jun 2017

Controversy between Obesity and Complications in Thromboembolic Disease, Series of Cases of Fuenlabrada University Hospital in Tinzaparine Treatment

Authors: B Losada, D Gutiérrez, I Juez, P Bravo, J Calzas, JA Guerra

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Thromboembolic disease is the second leading cause of death in cancer patients (mostly, in the first year from diagnosis). The needing for anticoagulation with low molecular weight heparin (LMWH) in patients who are at high risk for complications (risk of bleeding in digestive tumors, brain tumors ...) require us to be more aware of their evolution. In addition, presenting venous thromboembolic disease (VTE) is usually an exclusion criterion in clinical trials so we do not know what happens with the combination of new drugs. Our objective is to study in a sample of 31 patients diagnosed with VTE, whether incidence of complications such as re-thrombosis or bleeding is higher in patients treated with tinzaparin (LMWH) depending on BMI.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalJournal of Stem Cell Biology and Transplantation
  • SubjectGenetics & Molecular Biology
  • SubjectSurgery
  • BylineArticles whose byline prints “B Losada”
  • BylineArticles whose byline prints “D Gutiérrez”
  • BylineArticles whose byline prints “I Juez”
  • BylineArticles whose byline prints “P Bravo”
  • BylineArticles whose byline prints “J Calzas”
  • BylineArticles whose byline prints “JA Guerra”